Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation
Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexMale
Age18+
SponsorEMS
About this trial
The purpose of this study is to evaluate the efficacy and safety of Toronto association in the treatment of both sexual dysfunction: erectile dysfunction and premature ejaculation.
Eligibility criteria
Qualifiers
Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the informed consent forms;
Male participants, with age greater than or equal to 18 years;
Heterosexual, sexually active participants in a stable and monogamous relationship for at least 6 months before screening and who plan to maintain this relationship throughout the study period;
Participants with erectile dysfunction, in stable and effective treatment with PDE-5 inhibitors;
Disqualifiers
Any clinical and laboratory findings that, in the judgment of the investigator, may interfere with the safety of research participants;
Participation in a clinical trial in the year prior to this study;
Known hypersensitivity to any of the formula compounds;
Participants with cardiovascular disease for whom sexual activity is inadvisable
Trial design
Treatments tested in this trial
- Toronto association
- Tadalafil
- Tadalafil placebo
- Toronto association placebo
Treatment groups
232 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov